Regeneron Pharmaceuticals, Inc.
NOVEL IL10 AGONISTS AND METHODS OF USE THEREOF
Last updated:
Abstract:
The present disclosure relates to IL10 agonists with improved anti-tumor therapeutic efficacy.
Status:
Application
Type:
Utility
Filling date:
11 May 2021
Issue date:
18 Nov 2021